Latest & greatest articles for pneumonia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pneumonia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pneumonia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pneumonia

121. Community-Acquired Pneumonia.

Community-Acquired Pneumonia. In the Clinic: Community-Acquired Pneumonia. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26436631 Format MeSH and Other Data E-mail Subject Additional text E-mail Add (...) to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Oct 6;163(7):ITC1-17. doi: 10.7326/AITC201510060. In the Clinic: Community-Acquired Pneumonia. . PMID: 26436631 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substance Full Text Sources Medical PubMed Commons 0 comments How to cite this comment: Supplemental Content Full text links You are here: > > PubMed Simple NCBI Directory Getting Started

Annals of Internal Medicine2015

122. Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.

Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. IMPORTANCE: Few studies have evaluated the relationship between influenza vaccination and pneumonia, a serious complication of influenza infection. OBJECTIVE: To assess the association between influenza vaccination status and hospitalization for community-acquired laboratory-confirmed influenza pneumonia. DESIGN, SETTING, AND PARTICIPANTS: The Etiology (...) of Pneumonia in the Community (EPIC) study was a prospective observational multicenter study of hospitalizations for community-acquired pneumonia conducted from January 2010 through June 2012 at 4 US sites. In this case-control study, we used EPIC data from patients 6 months or older with laboratory-confirmed influenza infection and verified vaccination status during the influenza seasons and excluded patients with recent hospitalization, from chronic care residential facilities, and with severe

JAMA2015

124. Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial

Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

PedsCCM Evidence-Based Journal Club2015

125. Antibiotics for Community-Acquired Pneumonia in Adults.

Antibiotics for Community-Acquired Pneumonia in Adults. Antibiotics for Community-Acquired Pneumonia in Adults. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26267636 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 13;373(7):684-6. doi: 10.1056/NEJMc1506892. Antibiotics for Community-Acquired Pneumonia in Adults. , , . Comment on [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] PMID: 26267636 DOI: [Indexed for MEDLINE] Free full text Publication types MeSH terms Substances Full

NEJM2015

126. Antibiotics for Community-Acquired Pneumonia in Adults.

Antibiotics for Community-Acquired Pneumonia in Adults. Antibiotics for Community-Acquired Pneumonia in Adults. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26267637 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 13;373(7):683. doi: 10.1056/NEJMc1506892#SA1. Antibiotics for Community-Acquired Pneumonia in Adults. . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26267637 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons 0 comments How to cite

NEJM2015 Full Text: Link to full Text with Trip Pro

127. Antibiotics for Community-Acquired Pneumonia in Adults.

Antibiotics for Community-Acquired Pneumonia in Adults. Antibiotics for Community-Acquired Pneumonia in Adults. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26267638 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 13;373(7):683-4. doi: 10.1056/NEJMc1506892#SA2. Antibiotics for Community-Acquired Pneumonia in Adults. , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26267638 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons 0 comments How to cite

NEJM2015 Full Text: Link to full Text with Trip Pro

128. Antibiotics for Community-Acquired Pneumonia in Adults.

Antibiotics for Community-Acquired Pneumonia in Adults. Antibiotics for Community-Acquired Pneumonia in Adults. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26267639 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 13;373(7):684. doi: 10.1056/NEJMc1506892#SA3. Antibiotics for Community-Acquired Pneumonia in Adults. , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26267639 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons 0 comments How to cite

NEJM2015 Full Text: Link to full Text with Trip Pro

129. Antibiotics for Community-Acquired Pneumonia in Adults.

Antibiotics for Community-Acquired Pneumonia in Adults. Antibiotics for Community-Acquired Pneumonia in Adults. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26267640 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 13;373(7):684. doi: 10.1056/NEJMc1506892#SA4. Antibiotics for Community-Acquired Pneumonia in Adults. , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26267640 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons 0 comments How to cite

NEJM2015 Full Text: Link to full Text with Trip Pro

131. Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia

Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia 25614171 2015 06 01 2016 02 23 2016 11 25 1399-3003 45 6 2015 Jun The European respiratory journal Eur. Respir. J. Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia. 1624-31 10.1183/09031936.00199614 In patients with chronic eosinophilic pneumonia (CEP), dramatic improvements are seen in response to corticosteroid therapy; however, relapse is common after

EvidenceUpdates2015

132. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. BACKGROUND: Community-acquired pneumonia is a leading infectious cause of hospitalization and death among U.S. adults. Incidence estimates of pneumonia confirmed radiographically and with the use of current laboratory diagnostic tests are needed. METHODS: We conducted active population-based surveillance for community-acquired pneumonia requiring hospitalization among adults 18 years of age or older in five hospitals (...) in Chicago and Nashville. Patients with recent hospitalization or severe immunosuppression were excluded. Blood, urine, and respiratory specimens were systematically collected for culture, serologic testing, antigen detection, and molecular diagnostic testing. Study radiologists independently reviewed chest radiographs. We calculated population-based incidence rates of community-acquired pneumonia requiring hospitalization according to age and pathogen. RESULTS: From January 2010 through June 2012, we

NEJM2015

134. Outcomes in children with refractory pneumonia supported with extracorporeal membrane oxygenation

Outcomes in children with refractory pneumonia supported with extracorporeal membrane oxygenation PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

PedsCCM Evidence-Based Journal Club2015

135. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.

Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. BACKGROUND: Pneumonia remains the single leading cause of childhood mortality, causing an estimated 1.3 million childhood deaths each year in children under the age of five years. The greater burden of disease occurs in low-income countries, where medical resources and hospital-based management are poor. The World Health Organization (WHO (...) ) current evidence summaries recommend intravenous antibiotics for five days as first-line treatment for severe pneumonia. Although there is controversy around the specificity of clinical features in the diagnosis of pneumonia, the criteria for the diagnosis of severe pneumonia are better defined and widely used to triage children for referral and second-line therapy.Approximately 120 million new cases of pneumonia occur globally each year in children under five years of age, of which 14 million

Cochrane2015

136. Antibiotic treatment strategies for community-acquired pneumonia in adults.

Antibiotic treatment strategies for community-acquired pneumonia in adults. BACKGROUND: The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non-intensive care unit (ICU) hospital wards is complicated by the limited availability of evidence. We compared strategies of empirical treatment (allowing deviations for medical reasons) with beta-lactam monotherapy, beta-lactam-macrolide combination therapy

NEJM2015

137. Community-acquired pneumonia as medical emergency: predictors of early deterioration

Community-acquired pneumonia as medical emergency: predictors of early deterioration 25782758 2015 05 15 2015 09 04 2015 05 15 1468-3296 70 6 2015 Jun Thorax Thorax Community-acquired pneumonia as medical emergency: predictors of early deterioration. 551-8 10.1136/thoraxjnl-2014-206744 Early organ dysfunction determines the prognosis of community-acquired pneumonia (CAP), and recognition of CAP as a medical emergency has been advocated. To characterise patients with 'emergency CAP' and evaluate (...) therapeutic use Community-Acquired Infections diagnosis physiopathology Cough microbiology Emergencies Emergency Treatment methods Female Fever microbiology Follow-Up Studies Germany epidemiology Hospital Mortality Humans Intensive Care Units statistics & numerical data Male Middle Aged Pneumonia diagnosis microbiology mortality physiopathology therapy Predictive Value of Tests Prognosis Prospective Studies Research Design Risk Factors Sensitivity and Specificity Severity of Illness Index Sputum

EvidenceUpdates2015

138. Anticholinergic Medications and Risk of Community-Acquired Pneumonia in Elderly Adults: A Population-Based Case-Control Study

Anticholinergic Medications and Risk of Community-Acquired Pneumonia in Elderly Adults: A Population-Based Case-Control Study 25726764 2015 03 24 2015 06 01 2015 03 24 1532-5415 63 3 2015 Mar Journal of the American Geriatrics Society J Am Geriatr Soc Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study. 476-85 10.1111/jgs.13327 To determine whether use of anticholinergics is associated with risk of community-acquired (...) pneumonia in older adults. Population-based case-control study. An integrated healthcare delivery system in Washington State. Data from a nested case-control study of community-dwelling immunocompetent adults aged 65 to 94 were analyzed. Pneumonia cases (n=1,039) were ascertained according to International Classification of Diseases, Ninth Revision, codes from 2000 to 2003 and validated using chart review. Controls (n=2,022) were matched 2:1 to cases according to age, sex, and year. Anticholinergic

EvidenceUpdates2015

139. Lactate on emergency department arrival as a predictor of mortality and site-of-care in pneumonia patients: a cohort study

Lactate on emergency department arrival as a predictor of mortality and site-of-care in pneumonia patients: a cohort study 25716454 2015 04 14 2015 06 22 2015 11 19 1468-3296 70 5 2015 May Thorax Thorax Lactate on emergency department arrival as a predictor of mortality and site-of-care in pneumonia patients: a cohort study. 404-10 10.1136/thoraxjnl-2014-206461 To investigate the predictive performance of lactate, CURB-65, and a combination of lactate and CURB-65 (LAC-CURB-65) for mortality (...) , hospitalisation and intensive care unit (ICU) admission in pneumonia patients in the emergency department (ED). Consecutive adult patients with pneumonia presenting from January 2012 to May 2014 were divided into low-, moderate- and high-risk groups according to lactate (<2.0, 2.0-4.0, >4.0 mmol/L), CURB-65 (≤1, 2, ≥3) and LAC-CURB-65 (patients with two low risks, any moderate risk, any high risk) values. Mortality, hospitalisation and ICU admission rates were compared between risk classes. Of 1641 patients

EvidenceUpdates2015

140. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. 25785969 2015 03 19 2015 03 27 2015 07 06 1533-4406 372 12 2015 Mar 19 The New England journal of medicine N. Engl. J. Med. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. 1114-25 10.1056/NEJMoa1408544 Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in adults 65 years of age or older (...) is unknown. In a randomized, double-blind, placebo-controlled trial involving 84,496 adults 65 years of age or older, we evaluated the efficacy of 13-valent polysaccharide conjugate vaccine (PCV13) in preventing first episodes of vaccine-type strains of pneumococcal community-acquired pneumonia, nonbacteremic and noninvasive pneumococcal community-acquired pneumonia, and invasive pneumococcal disease. Standard laboratory methods and a serotype-specific urinary antigen detection assay were used

NEJM2015